Skip to main content

Table 2 Breakdown of different costs per diagnosed type 2 diabetes patient in the Singapore female working-age population by age group from 2010 to 2050 (in USD)

From: Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050

Year Age group Diabetes population Indirect productivity loss Total economic costa
Absenteeism Presenteeism Diabetes-related non-participation Lost capacity from premature mortality Total indirect cost
2010 20–29 1,451 122 1,313 - - 1,435 2,931
30–39 5,286 157 1,693 - 430 2,280 3,776
40–49 13,520 119 1,285 - 1,572 2,976 4,472
50–59 21,367 66 714 568 1,758 3,106 4,602
60–69 18,956 19 210 85 1,115 1,429 2,925
2030 20–29 2,028 182 1,955 - - 2,137 3,633
30–39 6,954 234 2,521 - 577 3,332 4,828
40−49 14,073 177 1,911 - 1,855 3,943 5,439
50–59 24,739 97 1,046 853 2,123 4,118 5,614
60–69 39,338 27 291 83 1,288 1,689 3,185
2050 20–29 2,180 273 2,937 - - 3,210 4,706
30–39 7,957 348 3,746 - 641 4,735 6,231
40–49 17,070 264 2,840 - 2,007 5,110 6,606
50–59 29,813 145 1,562 1,247 2,073 5,028 6,524
60–69 41,261 41 436 144 1,494 2,115 3,611
  1. aTotal economic cost = Total indirect cost + Excess direct medical cost of US$1,496.03